Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs) EQUITY
$65.32
pos +0.12
+0.18%
Today's Range: 65.20 - 65.80 | TEVA Avg Daily Volume: 4,739,800
Last Update: 08/28/15 - 10:46 AM EDT
Volume: 698,647
YTD Performance: 13.37%
Open: $65.20
Previous Close: $65.20
52 Week Range: $47.36 - $72.31
Oustanding Shares: 839,348,282
Market Cap: 54,406,555,639
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 8 9 10
Moderate Buy 2 0 0 0
Hold 6 6 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.88 2.07 2.11 2.05
Latest Dividend: 0.29
Latest Dividend Yield: 1.76%
Dividend Ex-Date: 08/18/15
Price Earnings Ratio: 43.50
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
43.50 21.90 24.79
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.41% 24.71% 61.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue -0.20 0.11 0.03
Net Income 142.80 0.10 0.03
EPS 138.50 0.15 0.05
Earnings for TEVA:
EBITDA 6.00B
Revenue 20.27B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.28 $1.27 $5.30 $5.43
Number of Analysts 20 20 22 23
High Estimate $1.33 $1.45 $5.45 $6.26
Low Estimate $1.22 $1.16 $5.15 $4.98
Prior Year $1.32 $1.31 $5.07 $5.30
Growth Rate (Year over Year) -3.18% -3.28% 4.55% 2.53%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Aug 1, 2015 | 9:00 AM EDT

Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their 'favorite company in the portfolio:' Allergan.

By

Bryan Ashenberg

 | Jul 30, 2015 | 9:22 AM EDT

There is building consensus around a September rate hike.

By

Bret Jensen

 | Jul 29, 2015 | 7:39 AM EDT
I'm happy as always to be standing in for Doug Kass on the Daily Diary.

bullishTeva upgraded at BMO

Jul 28, 2015 | 7:22 AM EDT

TEVA was upgraded to Outperform, BMO Capital said. $80 price target. Allergan deal makes the company a generic leader. 

By

Jim Cramer

 | Jul 27, 2015 | 4:00 PM EDT

Jim Cramer is watching Twitter (TWTR) as the social media giant releases earnings for its second quarter on Tuesday, July 28th after the market's closing bell.

By

Bret Jensen

 | Jul 27, 2015 | 1:00 PM EDT

This week could easily bring additional selling.

By

Jack Mohr

 | Jul 27, 2015 | 12:30 PM EDT

And we are raising our price target on AGN.

By

Antonia Oprita

 | Jul 27, 2015 | 5:30 AM EDT

And four other things you need to know now.

By

Sebastian Silva

 | Jul 26, 2015 | 7:23 PM EDT

Two tech companies in Jim Cramer's charitable trust report as well.

By

Robert Moreno

 | Jul 23, 2015 | 12:48 PM EDT

Pharmaceutical firm's chart shows a likely move to the upside.

TE Connectivity (TEL) announced this morning that they completed the sale of their Broadba...
Good Morning. Asian markets continued to move higher off the party in our markets yesterda...
We did finally see triggers against the last cycles in SPX, but I'm not convinced we won't...

Cost basis $197.60

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.